Gut Instinct | spotlight on Professor Borody | Health Agenda
Professor Borody is featured in Health Agenda “Gut Instinct – how our gut could be curing major diseases”.
All posts by: CDD
The Australian | Prof. Borody credited for saving Bob Hawke’s life
D’Alpuget credited Sydney gastroenterologist Thomas Borody — renowned globally for his innovative clinical work on complex gastrointestinal disorders — for saving the life of the great political slugger, devising the miraculous cocktail of specialist medicationss that saw the unsinkable Silver Bodgie live to slam another pint, though easy-drinking strawberry milkshakes are more his poison these […]
Science News | Crapsules at the CDD
But in Australia, the rules are different. Thomas Borody is a doctor there who founded the Centre for Digestive Diseases in Sydney. He has been giving people fecal transplants for various conditions, including C. difficile infection, since the late 1980s. Early on, he was one of a handful of doctors experimenting with the procedure. “I’ve been laughed at […]
A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Crohn’s Disease Status: Recruiting now ClinicalTrial.gov Identifier: NCT02405442 Aim: To evaluation the safety and efficacy of GS-5745 in adults with active Crohn’s disease. Single centre, open label Phase 1/Phase 2 study to evaluate the […]
Crestovo Doses Patients in PRISM 3, a Clinical Trial of CP101, a Microbiome Therapy for the Prevention of Recurrent Clostridium difficile Infection
CP101 is the lead, orally-administered product generated from Crestovo’s Full-Spectrum MicrobiotaTM (FSMTM) platform PRISM 3 includes 240 patients at clinical sites with broad coverage throughout the U.S. The company is based on foundational clinical research from gut microbiota-based treatment pioneers, Dr. Thomas J. Borody, Dr. Alexander Khoruts and Dr. Michael J. Sadowsky June 27, 2017 […]
Microbiome leader Professor Borody calls for a National Australian FMT Bank to fight Drug Resistant Diseases
SYDNEY, AUS, May 19, 2017 – (ACN Newswire) – Faecal Microbiota Transplantation (FMT) leader Professor Thomas Borody (MD, PhD) has called for a national faecal bank to fight drug resistant and epidemic diseases in hospitals and clinics across the country. Professor Borody, the Founder and Medical Director of the Centre for Digestive Diseases (CDD) in […]
Fecal Microbiota Transplant Induces Steroid-free Remission in Ulcerative Colitis Patients, Study Reports
A clinical study found that multi-donor fecal microbiota transplantation (FMT) successfully induced clinical and endoscopic remission in patients with resistant active ulcerative colitis (UC). Results from the placebo-controlled trial were presented at the recent 11th Congress of the European Crohn’s and Colitis Organisation (ECCO), held in Amsterdam, the Netherlands. Read more
Hot bowels
T here are varied reasons for inflammation of the colon, including Crohn’s, ulcerative colitis and various less common categories. Patients with chronic colonic inflammation, more commonly known as “hot bowels”, have increased susceptibility to develop bowel cancer. Hence, it is important to check the colon in these patients at least every three years and sometimes […]
New research findings
Prof Borody’s research interests have always been diverse and exciting, we now find ourselves at the forefront of emerging therapies for historical diseases. Neurological conditions such as Parkinson’s disease and Multiple Sclerosis (MS) and other conditions such as Coronary Heart Disease take on new meanings as we tackle them in our gastroenterological way. Coronary Heart […]
The business of poo
Faecal transplantation has taken on a new name recently decided upon by the North American Working Group in the area. It will now be called faecal microbiota transplant or FMT. This indicates that the origin of the bacteria is from faeces, Microbiota and in fact that we are Transplanting living cells. The stimulus for growing […]